ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC13300-10mg |
|
322-79-2 |
Triflusal
|
0 | C10H7F3O4 | |
GC13300-5mg |
|
322-79-2 |
Triflusal
|
0 | C10H7F3O4 | |
GC13299-50mg |
|
1216540-18-9 |
BX 513 hydrochloride
|
0 | C28H29ClN2O.HCl | |
GC13299-10mg |
|
1216540-18-9 |
BX 513 hydrochloride
|
0 | C28H29ClN2O.HCl | |
GC13298-50mg |
|
1217474-40-2 |
NAS-181
|
0 | C19H26N2O4.2CH3SO3H | |
GC13298-10mg |
|
1217474-40-2 |
NAS-181
|
0 | C19H26N2O4.2CH3SO3H | |
GC13297-10mM (in 1mL DMSO) |
|
850-52-2 |
Altrenogest
|
0 | C21H26O2 | |
GC13297-50mg |
|
850-52-2 |
Altrenogest
|
0 | C21H26O2 | |
GC13296-100mg |
|
439081-18-2 |
Afatinib(BIBW2992)
|
0 | C24H25ClFN5O3 | |
GC13296-10mM (in 1mL DMSO) |
|
439081-18-2 |
Afatinib(BIBW2992)
|
0 | C24H25ClFN5O3 | |
GC13296-10mg |
|
439081-18-2 |
Afatinib(BIBW2992)
|
0 | C24H25ClFN5O3 | |
GC13296-200mg |
|
439081-18-2 |
Afatinib(BIBW2992)
|
0 | C24H25ClFN5O3 | |
GC13296-50mg |
|
439081-18-2 |
Afatinib(BIBW2992)
|
0 | C24H25ClFN5O3 | |
GC13295-100mg |
|
82266-85-1 |
Impurity C of Alfacalcidol
|
0 | C35H49N3O4 | |
GC13294-25mg |
|
388575-52-8 |
PSN 375963 hydrochloride
|
0 | C17H23N3O.HCl | |
GC13294-10mg |
|
388575-52-8 |
PSN 375963 hydrochloride
|
0 | C17H23N3O.HCl | |
GC13294-5mg |
|
388575-52-8 |
PSN 375963 hydrochloride
|
0 | C17H23N3O.HCl | |
GC13293-10mM (in 1mL DMSO) |
|
1040526-12-2 |
LP533401 hcl
|
0 | C27H23ClF4N4O3 | |
GC13293-100mg |
|
1040526-12-2 |
LP533401 hcl
|
0 | C27H23ClF4N4O3 | |
GC13293-50mg |
|
1040526-12-2 |
LP533401 hcl
|
0 | C27H23ClF4N4O3 | |